Please login to the form below

Not currently logged in
Email:
Password:

The Royal Marsden

This page shows the latest The Royal Marsden news and features for those working in and with pharma, biotech and healthcare.

Innovating patient care

Innovating patient care

His institution is also part of a vanguard project with London hospitals the Royal Marsden and UCLH. “ ... If we get it right between the Christie, the Royal Marsden and UCLH, it will hopefully provide a template.”.

Latest news

  • BMS launches Opdivo for lung cancer in UK BMS launches Opdivo for lung cancer in UK

    Commenting on the launch for lung cancer, Dr Sanjay Popat of the Royal Marsden hospital said: "This group of patients with relapsed squamous-type lung cancer represents a considerable unmet medical ... need in the UK, as chemotherapy has been their main

  • NHS sponsors charity on metastatic breast cancer study NHS sponsors charity on metastatic breast cancer study

    With funding from Walk the Walk and sponsorship by The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research (ICR), London, the LEGACY study allows patients with secondary breast ... Peter Barry, consultant oncoplastic breast surgeon at

  • Personalised cancer medicines showcased in BBC investigation Personalised cancer medicines showcased in BBC investigation

    efficacy. In the Panorama investigation, the editorial team spent two years filming at the Royal Marsden Hospital and its Institute of Cancer Research arm in London, and followed a number of ... Doctors at the Royal Marsden used Novartis' Zykadia

  • Boehringer's oncology unit scores first EU approval Boehringer's oncology unit scores first EU approval

    cancers associated with a high mortality such as lung cancer", said Dr Sanjay Popat of the Royal Marsden NHS Foundation Trust in the UK, and lead investigator in Giotrif's pivotal ... Boehringer has plans to extend the indications for Giotrif into breast

  • NICE recommends test to support choice of breast cancer treatment NICE recommends test to support choice of breast cancer treatment

    the evidence that these tests can predict the level of response in chemotherapy is “ uncertain”. ... Cancer at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research (ICR), comes at a cost between £100 and £200.

More from news
Approximately 2 fully matching, plus 22 partially matching documents found.

Latest from PMHub

  • Leading the conversation in oncology

    We have fostered unique working partnerships with organisations such as The Royal Marsden Hospital and e cancer, Europe’ s leading oncology channel, and are proud of our long-standing role as ... The Royal Marsden Hospital NHS Foundation Trust, London.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics